EZ-editor platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout model development for life science research A stable Gene Knockout Cell Line can ...
New Phase I/II RGX-202 functional data demonstrates long-term, durable treatment effect at pivotal dose at 18 months Robust patient enrollment in confirmatory trial continues, expect majority of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results